Alimera Sciences (NASDAQ:ALIM) Research Coverage Started at StockNews.com

StockNews.com assumed coverage on shares of Alimera Sciences (NASDAQ:ALIM – Free Report) in a research report sent to investors on Tuesday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Other equities research analysts also recently issued reports about the company. Alliance Global Partners reaffirmed a neutral rating on shares of Alimera Sciences […]

Leave a Reply

Your email address will not be published.

Previous post MRC Global (NYSE:MRC) Rating Lowered to Buy at StockNews.com
Next post Private Capital Management LLC Sells 50 Shares of JPMorgan Chase & Co. (NYSE:JPM)